SCHEMBL6681909

SCHEMBL6681909

CC(C)(C)OC(=O)NN(Cc1cccc([N+](=O)[O-])c1)C(=O)OC(C)(C)C

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKT1 P31749 3/20 0.51
MAPT P10636 2/20 0.49
ALOX5 P09917 1/20 0.49
NPC1 O15118 1/20 0.49
RAB9A P51151 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
ALDH1A1 P00352 1/20 0.49
LMNA P02545 1/20 0.49
CYP2D6 P10635 2/20 0.48
CYP2C9 P11712 2/20 0.48
CYP2C19 P33261 2/20 0.48
CYP1A2 P05177 1/20 0.48
ACHE P22303 1/20 0.45
MMP1 P03956 1/20 0.44
MMP2 P08253 1/20 0.44
MMP9 P14780 1/20 0.44
MMP8 P22894 1/20 0.44
MMP13 P45452 1/20 0.44
PYCR1 P32322 1/20 0.44
ITGA4 P13612 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16107405 0.87 MAPT (0.43) MAPTALOX5NPC1RAB9ASMN1; SMN2
SCHEMBL6679985 0.83 CYP2D6 (0.51) MAPTALOX5NPC1RAB9ASMN1; SMN2
SCHEMBL3296353 0.82 PYCR1 (0.51) MAPTALOX5NPC1RAB9ASMN1; SMN2
SCHEMBL2394937 0.81 AKT1 (0.53) AKT1MAPTNPC1RAB9ASMN1; SMN2
SCHEMBL16107703 0.81 CYP2D6 (0.49) MAPTALOX5NPC1RAB9ASMN1; SMN2
SCHEMBL6676802 0.81 AKT1 (0.55) AKT1
SCHEMBL399471 0.81 CYP2D6 (0.49) MAPTALOX5NPC1RAB9ASMN1; SMN2
SCHEMBL6674347 0.80 CYP1A2 (0.54) MAPTALOX5NPC1RAB9ASMN1; SMN2
SCHEMBL6284908 0.80 PYCR1 (0.49) MAPTALOX5NPC1RAB9ASMN1; SMN2
SCHEMBL1402743 0.80 AKT1 (0.57) AKT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0798292-B1 ANILINE DERIVATIVES HAVING NITROGEN MONOXIDE SYNTHASE INHIBITORY ACTIVITY CHUGAI SEIYAKUKABUSHIKI KAISHA (JP) 2004-11-03 EP disclosed
US-6534546-B1 Guanidine- or isothioureido-N-derived anilines; brain, nervous system, and neurodegenerative disorders CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) 2003-03-18 US disclosed
EP-0798292-A1 ANILINE DERIVATIVES HAVING NITROGEN MONOXIDE SYNTHASE INHIBITORY ACTIVITY Chugai Seiyaku Kabushiki Kaisha (JP) 1997-10-01 EP disclosed